Does ROSUVASTATIN Cause Hepatic cancer? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hepatic cancer have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
26
Reports of Hepatic cancer with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
22
Deaths
3
Hospitalizations
How Dangerous Is Hepatic cancer From ROSUVASTATIN?
Of the 26 reports, 22 (84.6%) resulted in death, 3 (11.5%) required hospitalization.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
ADALIMUMAB (193)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
Which ROSUVASTATIN Alternatives Have Lower Hepatic cancer Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN